A Silicon Valley venture capital firm with a successful track record in the tech industry announced that it’s throwing considerable finances behind a California startup that’s aiming to bring a marijuana breathalyzer to market.
Benchmark Capital – which previously funded successful startups including Dropbox, Uber and Snap – is leading a new $8.1 million round of fundraising for Oakland-based Hound Labs, according to Business Insider.
For instance, in Colorado the legal limit of active THC in a driver’s bloodstream is five nanograms, but the only reliable way for police to detect such levels is through a blood test, as opposed to a roadside breathalyzer for alcohol.
Hound Labs’ product will retail for between $600 and $1,000, Business Insider reported, and cartridges that store samples will cost about $15 apiece.
Amid growing criticism, NCIA chief Aaron Smith admits missteps and hopes to move the trade group in a new direction.
Sigh….when will people learn that the human body is a complex organism that can’t be accurately tested for THC without benchmarks. Talk to any competent medical professional and they will discuss fat solubility, body composition, frequency of use, metabolism…
ITS A BULL**** IDEA TO START WITH AND HAS NO BASIS FOR IT TO WORK, A POLITICAL WAY TO “SCARE” USERS INTO STOPPING USE. A BACKDOOR PROBHINIST MOVE.